305 related articles for article (PubMed ID: 27240501)
1. Comparative antibacterial activity of topical antiseptic eardrops against methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Youn CK; Jang SJ; Jo ER; Choi JA; Sim JH; Cho SI
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():80-3. PubMed ID: 27240501
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacies of topical antiseptic eardrops against biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Youn CK; Jun Y; Jo ER; Jang SJ; Song H; Cho SI
J Laryngol Otol; 2018 Jun; 132(6):519-522. PubMed ID: 29909794
[TBL] [Abstract][Full Text] [Related]
3. The appropriate medical management of methicillin-resistant Staphylococcus aureus in chronic suppurative otitis media.
Choi HG; Park KH; Park SN; Jun BC; Lee DH; Yeo SW
Acta Otolaryngol; 2010; 130(1):42-6. PubMed ID: 19424918
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Jun Y; Youn CK; Jo ER; Cho SI
Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109622. PubMed ID: 31404783
[TBL] [Abstract][Full Text] [Related]
5. Change in Detection Rate of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa and Their Antibiotic Sensitivities in Patients with Chronic Suppurative Otitis Media.
Kim SH; Kim MG; Kim SS; Cha SH; Yeo SG
J Int Adv Otol; 2015 Aug; 11(2):151-6. PubMed ID: 26381007
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial effects of Burow's solution on Staphylococcus aureus and Pseudomonas aeruginosa.
Hyo Y; Yamada S; Ishimatsu M; Fukutsuji K; Harada T
Med Mol Morphol; 2012 Jun; 45(2):66-71. PubMed ID: 22718290
[TBL] [Abstract][Full Text] [Related]
7. [Pharmaceutical and pharmacological evaluation of Burow's solution (aluminum acetate solution), hospital preparation, and development of its rapid preparation method].
Ishibashi Y; Murakami T; Yumoto R; Sakai M; Shintani H; Itaha H; Kanbe M; Masuda S; Yajin K; Kihira K; Takano M
Yakugaku Zasshi; 2004 Nov; 124(11):833-40. PubMed ID: 15516810
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of MRSA colonized middle ear; case report and literature review].
Senska G; Rüsing D
Laryngorhinootologie; 2010 Jul; 89(7):404-8. PubMed ID: 20617476
[TBL] [Abstract][Full Text] [Related]
9. Lugol's solution eradicates Staphylococcus aureus biofilm in vitro.
Grønseth T; Vestby LK; Nesse LL; Thoen E; Habimana O; von Unge M; Silvola JT
Int J Pediatr Otorhinolaryngol; 2017 Dec; 103():58-64. PubMed ID: 29224767
[TBL] [Abstract][Full Text] [Related]
10. Anti-microbial and therapeutic effects of modified Burow's solution on refractory otorrhea.
Jinnouchi O; Kuwahara T; Ishida S; Okano Y; Kasei Y; Kunitomo K; Takeda N
Auris Nasus Larynx; 2012 Aug; 39(4):374-7. PubMed ID: 21862264
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings.
Loock JW
Clin Otolaryngol; 2012 Aug; 37(4):261-70. PubMed ID: 22804826
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of bacteria Pseudomonas aeruginosa and MRSA associated with chronic suppurative otitis media.
Rath S; Das SR; Padhy RN
Braz J Otorhinolaryngol; 2017; 83(2):201-206. PubMed ID: 27177975
[TBL] [Abstract][Full Text] [Related]
13. The antibacterial activity of acetic acid and Burow's solution as topical otological preparations.
Thorp MA; Kruger J; Oliver S; Nilssen EL; Prescott CA
J Laryngol Otol; 1998 Oct; 112(10):925-8. PubMed ID: 10211213
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of Burow's solution as an ear preparation for the treatment of chronic ear infections.
Kashiwamura M; Chida E; Matsumura M; Nakamaru Y; Suda N; Terayama Y; Fukuda S
Otol Neurotol; 2004 Jan; 25(1):9-13. PubMed ID: 14724484
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid/boric acid impregnated cleansing wipes.
Rafferty R; Robinson VH; Harris J; Argyle SA; Nuttall TJ
BMC Vet Res; 2019 Oct; 15(1):382. PubMed ID: 31666075
[TBL] [Abstract][Full Text] [Related]
16. Bacteriological Profile of Chronic Suppurative Otitis Media and Antibiotic Susceptibility in a Tertiary Care Hospital in Shanghai, China.
Xu J; Du Q; Shu Y; Ji J; Dai C
Ear Nose Throat J; 2021 Nov; 100(9):NP391-NP396. PubMed ID: 32352873
[TBL] [Abstract][Full Text] [Related]
17. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 4,6-di(substituted)amino-1,2-dihydro-1,3,5-triazine derivatives as topical antiseptic agents.
Maeda S; Kita T; Meguro K
J Med Chem; 2009 Feb; 52(3):597-600. PubMed ID: 19117423
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000.
Lambert RJ
J Appl Microbiol; 2004; 97(4):699-711. PubMed ID: 15357719
[TBL] [Abstract][Full Text] [Related]
20. 0.01% Hypochlorous Acid as an Alternative Skin Antiseptic: An In Vitro Comparison.
Anagnostopoulos AG; Rong A; Miller D; Tran AQ; Head T; Lee MC; Lee WW
Dermatol Surg; 2018 Dec; 44(12):1489-1493. PubMed ID: 29985866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
